Refractory diffuse large B-cell Lymphoma
Main Authors: | Hajar Masrour, Latifa Lerhrib, Sanaa Bouchnafati, Widad Rhandour, Mounia Bouzayd, Laila Abarkan, Anas Oudrhiri, Nabil Al Saddiq, Rim Hanini, Yassine Chekkori, Falah Eddine Tohir, Ouazzani, Naoual Oubelkacem, Noufissa Alami Drideb, Zineb Khammar, Rhizlane Berrady |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Journal of Taibah University Medical Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1658361223001713 |
Similar Items
-
Adverse effects of Imatinib in patients with chronic myeloid leukemia
by: Hajar Masrour, et al.
Published: (2023-01-01) -
CD5 expression in diffuse large B-cell lymphoma
by: Sanaa Bouchnafati, et al.
Published: (2023-01-01) -
BCL2 overexpression in diffuse large B-cell Lymphoma
by: Hajar Masrour, et al.
Published: (2023-01-01) -
The Bulky mass in diffuse large B Cell Lymphoma: Prognostic impact? A treatment guiding factor?
by: Masrour, et al.
Published: (2023-01-01) -
Molecular Classification of Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma Cases and Association with Outcomes in Morocco
by: Mahat Taybi, et al.
Published: (2024-10-01)